论文部分内容阅读
目的探讨注射用乳糖酸阿奇霉素治疗小儿支气管肺炎的临床疗效及安全性。方法回顾性分析2008年2月至2010年5月期间,在我院收治的80例小儿支气管肺炎患儿,随机分为治疗组与对照组,每组各40例。治疗组给予注射用乳糖酸阿奇霉素,对照组给予注射用阿莫西林克拉维酸钾,密切观察两组患者的临床疗效。结果乳糖酸阿奇霉素治疗小儿支气管肺炎的总有效率高于对照组的总有效率,且乳糖酸阿奇霉素组的不良反应发生率明显低于对照组。结论乳糖酸阿奇霉素是治疗小儿支气管肺炎临床疗效确切有效、安全性高的抗生素的方法。
Objective To investigate the clinical efficacy and safety of injection of azithromycin lactobion in children with bronchial pneumonia. Methods A retrospective analysis of 80 children with bronchopneumonia admitted to our hospital from February 2008 to May 2010 was randomly divided into treatment group and control group, 40 cases in each group. The treatment group was given injection of azithromycin lactobionate, the control group was given amoxicillin injection of clavulanic acid potassium, and the clinical efficacy of the two groups was observed closely. Results The total effective rate of azithromycin lactobionate treatment of children with bronchial pneumonia was higher than that of the control group, and the incidence of adverse reactions in azithromycin lactobionate group was significantly lower than that of the control group. Conclusion Azithromycin lactobionate is an effective and safe antibiotic for the treatment of bronchial pneumonia in children.